Next Article in Journal
Ameliorative Effects of Taurine Against Methimazole-Induced Cytotoxicity in Isolated Rat Hepatocytes
Previous Article in Journal
Novel Validated Stability-Indicating UPLC Method for the Estimation of Naproxen and its Impurities in Bulk Drugs and Pharmaceutical Dosage Form
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Validated Stability-Indicating HPLC Method for Routine Analysis of an Injectable Lincomycin and Spectinomycin Formulation

by
Murad N. ABUALHASAN
1,*,
Nidal BATRAWI
2,
Oliver B. SUTCLIFFE
3 and
Abdel Naser ZAID
1
1
Department of Pharmacy, An-Najah National University, Nablus, Palestine
2
Advanced Veterinary Company, Ramallah, Palestine
3
Division of Chemistry & Environmental Science, School of Science and the Environment, Manchester Metropolitan University, Manchester, United Kingdom
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2012, 80(4), 977-986; https://doi.org/10.3797/scipharm.1207-13
Submission received: 16 July 2012 / Accepted: 10 September 2012 / Published: 10 September 2012

Abstract

Lincomycin and spectinomycin combination therapy is widely used in veterinary medicine for the treatment of gastrointestinal and respiratory infections caused by lincomycin- and spectinomycin-sensitive microorganisms. A simple, reverse phase HPLC method for the analysis of samples of an injectable lincomycin and spectinomycin preparation containing a mixture of inactive excipients has been developed. The HPLC was carried out using the RP-C18 (250 mm × 4.0 mm, 5 μm) column, with the gradient mobile phase consisting of an acetonitrile and phosphate buffer at pH 6; the flow rate of 1 mL/min and ultraviolet detection at 220 nm. This method was validated in accordance with both FDA and ICH guidelines and showed good linearity, accuracy, precision, selectivity, and system suitability results within the acceptance criteria. A stability-indicating study was also carried out and indicated that this method can also be used for purity and degradation evaluation of these formulations.
Keywords: Stability-Indicating; RP-HPLC; Lincomycin; Spectinomycin Stability-Indicating; RP-HPLC; Lincomycin; Spectinomycin

Share and Cite

MDPI and ACS Style

ABUALHASAN, M.N.; BATRAWI, N.; SUTCLIFFE, O.B.; ZAID, A.N. A Validated Stability-Indicating HPLC Method for Routine Analysis of an Injectable Lincomycin and Spectinomycin Formulation. Sci. Pharm. 2012, 80, 977-986. https://doi.org/10.3797/scipharm.1207-13

AMA Style

ABUALHASAN MN, BATRAWI N, SUTCLIFFE OB, ZAID AN. A Validated Stability-Indicating HPLC Method for Routine Analysis of an Injectable Lincomycin and Spectinomycin Formulation. Scientia Pharmaceutica. 2012; 80(4):977-986. https://doi.org/10.3797/scipharm.1207-13

Chicago/Turabian Style

ABUALHASAN, Murad N., Nidal BATRAWI, Oliver B. SUTCLIFFE, and Abdel Naser ZAID. 2012. "A Validated Stability-Indicating HPLC Method for Routine Analysis of an Injectable Lincomycin and Spectinomycin Formulation" Scientia Pharmaceutica 80, no. 4: 977-986. https://doi.org/10.3797/scipharm.1207-13

APA Style

ABUALHASAN, M. N., BATRAWI, N., SUTCLIFFE, O. B., & ZAID, A. N. (2012). A Validated Stability-Indicating HPLC Method for Routine Analysis of an Injectable Lincomycin and Spectinomycin Formulation. Scientia Pharmaceutica, 80(4), 977-986. https://doi.org/10.3797/scipharm.1207-13

Article Metrics

Back to TopTop